| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | | | | | | | |
| Selling, general and administrative [+] | 8.1 | 2.8 | 1.8 | 7.4 | 6.6 | 6.3 | 6.1 | 6.3 |
| General and administrative | 8.1 | 2.8 | 1.8 | 7.4 | 6.6 | 6.3 | 6.1 | 6.3 |
| Research and development | 15.2 | 6.6 | 2.4 | 13.1 | 10.7 | 10.1 | 12.1 | 7.0 |
| EBITDA [+] | -22.7 | -9.5 | -4.2 | -20.5 | -17.3 | -16.4 | -18.2 | -13.2 |
| EBITDA growth | 140.0% | 125.7% | -79.6% | 18.4% | 5.7% | -10.2% | 37.7% | 66.7% |
| EBITDA margin | -3854.2% | | | | | | | |
| Depreciation and amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBIT [+] | -22.7 | -9.5 | -4.2 | -20.5 | -17.4 | -16.4 | -18.3 | -13.3 |
| EBIT growth | 139.9% | 125.8% | -79.6% | 18.3% | 5.7% | -10.1% | 37.6% | 66.3% |
| EBIT margin | -3854.8% | | | | | | | |
| Non-recurring items [+] | | 10.5 | | | | | | |
| In-process research & development | | 10.5 | | | | | | |
| Interest expense, net [+] | 0.0 | 6.8 | 1.4 | -0.3 | -0.2 | -0.1 | -0.1 | -0.1 |
| Interest expense | 0.0 | 6.8 | 1.4 | | | | | |
| Interest income | | | | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 |
| Other income (expense), net [+] | -34.0 | 2.2 | -0.6 | 5.9 | -8.1 | 7.0 | 3.8 | -5.4 |
| Litigation settlement | | | | | | 1.8 | | |
| Gain (loss) on debt retirement | | 3.7 | | | | | | |
| Unrealized gain/loss on derivatives | -33.8 | -1.5 | -0.5 | | | | | |
| Change in fair value of warrants | -33.8 | -1.5 | -0.5 | 5.5 | -7.6 | | | |
| Other non-operating income | | | | 0.4 | | | | |
| Other | -0.2 | 0.0 | -0.1 | 0.4 | | | | -5.3 |
| Pre-tax income | -56.7 | -24.6 | -6.2 | -14.4 | -25.3 | -9.3 | -14.4 | -18.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -56.7 | -24.6 | -6.2 | -14.4 | -25.3 | -9.3 | -14.4 | -18.5 |
| Net margin | -9625.3% | | | | | | | |
| |
| Basic EPS [+] | ($3.82) | ($5.28) | ($2.17) | ($5.25) | ($0.92) | ($0.43) | ($0.79) | ($0.11) |
| Growth | -27.7% | 143.6% | -58.7% | 468.2% | 115.8% | -45.7% | 649.9% | 42.4% |
| Diluted EPS [+] | ($3.82) | ($5.28) | ($2.17) | ($5.25) | ($0.92) | ($0.43) | ($0.79) | ($0.11) |
| Growth | -27.7% | 143.6% | -58.7% | 468.2% | 115.8% | -45.7% | 649.9% | 42.4% |
| |
| Shares outstanding (basic) [+] | 14.9 | 4.7 | 2.8 | 2.7 | 27.4 | 21.7 | 18.2 | 176.1 |
| Growth | 218.7% | 63.8% | 3.9% | -90.0% | 26.0% | 19.2% | -89.6% | 36.9% |
| Shares outstanding (diluted) [+] | 14.9 | 4.7 | 2.8 | 2.7 | 27.4 | 21.7 | 18.2 | 176.1 |
| Growth | 218.7% | 63.8% | 3.9% | -90.0% | 26.0% | 19.2% | -89.6% | 36.9% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |